Su Cui
Overview
Explore the profile of Su Cui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
135
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang H, Zhang G, Xiao M, Cui S, Jin C, Yang J, et al.
J Exp Clin Cancer Res
. 2024 Aug;
43(1):237.
PMID: 39164746
Background: Activator protein-1 (AP-1) represents a transcription factor family that has garnered growing attention for its extensive involvement in tumor biology. However, the roles of the AP-1 family in the...
2.
Zhao S, Xiao M, Li L, Zhang H, Shan M, Cui S, et al.
Sci Total Environ
. 2024 Mar;
923:171349.
PMID: 38438030
Benzo(a)pyrene as a pervasive environmental contaminant is characterized by its substantial genotoxicity, and epidemiological investigations have established a correlation between benzo(a)pyrene exposure and the susceptibility to human lung cancer. Notably,...
3.
Cui S, Han Y, Duan Y, Li Y, Zhu S, Song C
Entropy (Basel)
. 2023 May;
25(4).
PMID: 37190343
In recent years, social network sentiment classification has been extensively researched and applied in various fields, such as opinion monitoring, market analysis, and commodity feedback. The ensemble approach has achieved...
4.
Zhang H, Zhang G, Zhang J, Xiao M, Cui S, Wu S, et al.
Biochem Pharmacol
. 2022 Nov;
206:115344.
PMID: 36372331
Tobacco remains the most common environmental carcinogen leading to the occurrence and development of lung cancer. Nicotine, a tumor promoter in cigarette smoke, has been shown to induce epithelial-mesenchymal transition...
5.
Xue P, Zhang G, Zhang H, Cui S, Zhang L, Yu T, et al.
J Cell Mol Med
. 2022 Oct;
26(21):5439-5451.
PMID: 36181289
Platinum-based chemotherapy is regarded as a preferential curative-intent option for non-small cell lung cancer (NSCLC), while the acquired drug resistance has become a major obstacle that limits its clinical application....
6.
Zhang G, Yu T, Zhang Q, Zhang H, Xiao M, Cui S, et al.
Chem Biol Interact
. 2021 Oct;
349:109683.
PMID: 34610339
Previous studies have shown that PPP1R13L as an inhibitor of apoptosis protease TP53 can lead to abnormal cell proliferation and carcinogenesis, however, the function of PPP1R13L was complicated and the...
7.
Xiao M, Cui S, Zhang L, Yu T, Zhang G, Li L, et al.
Mol Carcinog
. 2021 Jul;
60(10):684-701.
PMID: 34320692
ERCC1 is a gene for repairing DNA damage whose function is related to carcinogenic-induced tumorigenesis and the effectiveness of platinum therapies. Circular RNAs (circRNAs) are products of posttranscriptional regulation with...
8.
Cui S, Yang C, Chen D
Biochem Genet
. 2021 Apr;
59(6):1441-1456.
PMID: 33928467
The aim of the study is to investigate how lncRNA EWSAT1 regulates the tumorigenesis of non-small cell lung cancer (NSCLC) as a ceRNA by modulating miR-330-5p/ITGA5 axis. qRT-PCR was conducted...
9.
Xiao M, Cui S, Zhang L, Yu T, Zhang G, Zhang Q, et al.
J Cancer
. 2019 Jul;
10(16):3608-3617.
PMID: 31333777
Lung cancer is one of the most devastating tumors with a high incidence and mortality worldwide. Polymorphisms and expression of commonly predicted the occurrence and prognosis of lung cancer. However,...
10.
Yu T, Xue P, Cui S, Zhang L, Zhang G, Xiao M, et al.
Cancer Med
. 2018 Nov;
7(12):6317-6330.
PMID: 30453383
Single nucleotide polymorphisms (SNPs) in 3'UTR of key DNA repair enzyme genes are associated with inter-individual differences of DNA repair capacity (DRC) and susceptibility to a variety of human malignancies...